← Back to headlines
Axsome Therapeutics Highlights Auvelity Momentum and Sales Push at Oppenheimer Conference
Axsome Therapeutics discussed the strong performance of its drug Auvelity, its strategy for a 600-representative sales force, and an upcoming PDUFA date at the Oppenheimer Conference.
26 Feb, 02:10 — 26 Feb, 02:10
Sources
Showing 1 of 1 sources
